Novavax, Inc. Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$7.28$7.64
2.28%
Downside
2.55%
Upside
52 Week's Low
52 Week's High
$5.01$11.5532.75%
Downside
55.03%
Upside
Novavax, Inc. share price movements today
- Previous Close
- $7.59
- Open
- $7.48
- Volume
- 4.8M
- Day's Low - High
- $7.28 - $7.64
- 52 Week Low - High
- $5.01 - $11.55
Novavax, Inc. Historical Returns
- 1 Month Return
- -16.4 %
- 3 Month Return
- -11.11 %
- 1 Year Return
- -16.5 %
- 3 Year Return
- -62.14 %
- 5 Year Return
- -91.72 %
Novavax, Inc. Stock Fundamentals & Key Indicators
Check Novavax, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
2.1569
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.38%
PE Ratio (TTM)
3.42
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
407.5M
Revenue (TTM)
1.1B
Profit Margin
39.20%
Return On Equity TTM
-898.20%
Novavax, Inc. Stock Valuation
Track how Novavax, Inc. P/E has moved over time to understand its valuation trends.
Novavax, Inc. in the last 5 years
Lowest (-21.52x)
March 31, 2021
Industry (-0.81x)
November 8, 2025
Today (3.42x)
November 8, 2025
Highest (3.13x)
March 31, 2025
Today’s Price to Earnings Ratio: 3.42x
Novavax, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Novavax, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | -91.72% | 3.42 | 39.20% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Stock Returns calculator for Novavax, Inc. Stock including INR - Dollar returns
The Novavax, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novavax, Inc. investment value today
Current value as on today
₹88,761
Returns
Returns from Novavax, Inc. Stock
Dollar Returns*
₹5,147 (+5.15%)
Analyst Recommendation on Novavax, Inc. Stock
Based on 12 analysts
66.67%
Buy
16.67%
Hold
16.67%
Sell
Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Novavax, Inc.. Average target price of $13.21
Novavax, Inc. Share Price Target
Get share price movements and forecasts by analysts on Novavax, Inc..
What analysts predicted
43.6%UPSIDE
Target Price
$13.21
Current Price
$7.45
Analyzed by
12 Analysts
Target
$13.21
Novavax, Inc. target price $13.21, a slight upside of 43.6% compared to current price of $7.45. According to 12 analysts rating.
Novavax, Inc. Stock’s Investor Sentiment and Interest
Search interest for Novavax, Inc. Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Novavax, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Novavax, Inc. Annual Profit & Loss
All numbers in Millions USD
Novavax, Inc. Quarterly Cash Flow
All numbers in Millions USD
Novavax, Inc. Annual Cash Flow
All numbers in Millions USD
Novavax, Inc. News & Key Events
Today's Timeline - 06 November
Thu, 06:35 PM
-Novavax reports Q3 2025 revenue of $70 million, net loss widens to $202 million, and raises 2025 revenue forecast.
Thu, 06:37 PM
-Novavax raises annual revenue forecast for 2025, citing vaccine deals despite ongoing investor pressure over COVID-19 vaccine sales.
Fri, 02:26 AM
-Novavax delays profitability target to 2028, awaiting Sanofi-led product launches and facing investor pressure over sluggish vaccine sales.
Insights on Novavax, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 167.3%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 958.6%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 666.65M → 239.24M (in $), with an average decrease of 64.1% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 518.64M → 106.50M (in $), with an average decrease of 79.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, NVAX stock has moved down by -9.6%
About Novavax, Inc.
| Organisation | Novavax, Inc. |
| Headquarters | 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 |
| Industry | Health Technology |
| CEO | Mr. John Charles Jacobs M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Novavax, Inc.
Name | Title |
|---|---|
Mr. Mark J. Casey Esq. | Executive VP, Chief Legal Officer & Corporate Secretary |
Ms. Elaine O'Hara | Executive VP & Chief Strategy Officer |
Mr. Richard P. Crowley | Executive VP & COO |
Mr. Troy Morgan Esq., J.D. | Senior VP, Deputy General Counsel & Chief Compliance Officer |
Dr. Henrietta Ukwu FACP FRAPS, M.D. | Executive VP & Chief Regulatory Officer |
Mr. John Charles Jacobs M.B.A. | President, CEO & Director |
Mr. James Patrick Kelly C.F.A. | Executive VP, CFO & Treasurer |
Ms. Erika S. Trahan | Associate Director of Investor & Public Relations |
Mr. Ian J. Watkins | Executive VP & Chief Human Resources Officer |
Ms. Silvia Taylor M.B.A. | Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden |
FAQs
What is Novavax, Inc. share price today?
Novavax, Inc. share price today is $7.45 as on at the close of the market. Novavax, Inc. share today touched a day high of $7.64 and a low of $7.28.
What is the 52 week high and 52 week low for Novavax, Inc. share?
Novavax, Inc. share touched a 52 week high of $11.55 on and a 52 week low of $5.01 on . Novavax, Inc. stock price today i.e. is closed at $7.45,which is 35.50% down from its 52 week high and 48.70% up from its 52 week low.
What is Novavax, Inc.'s market capitalisation today?
Novavax, Inc. market capitalisation is $0.00T as on .
How to invest in Novavax, Inc. Stock (NVAX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Novavax, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novavax, Inc. Shares that will get you 0.2013 shares as per Novavax, Inc. share price of $7.45 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Novavax, Inc. Stock (NVAX) from India?
Indian investors can start investing in Novavax, Inc. (NVAX) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Novavax, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novavax, Inc. share’s latest price of $7.45 as on November 8, 2025 at 2:29 am IST, you will get 1.3423 shares of Novavax, Inc.. Learn more about
fractional shares .
What are the returns that Novavax, Inc. has given to Indian investors in the last 5 years?
Novavax, Inc. stock has given -91.72% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?